Citations

Showing 10 of 108162 citations.

Effects of a 16-Week Multimodal Exercise Program on Physical Performance in Individuals With Dementia: A Multicenter Randomized Controlled Trial
Barisch‐Fritz, Bettina , Trautwein, Sandra , Scharpf, Andrea , Krell‐Roesch, Janina , Wöll, Alexander

Mayo Clinic

Journal of Geriatric Physical Therapy | April 4, 2021 | Volume: 45 | Issue: 1 | Pages: 3-24

10.1519/jpt.0000000000000308 | PMID 33813533 Get It

Background and Purpose: Dementia affects physical as well as cognitive performance. In individuals with dementia (IWD), decline in physical performance increases with disease progression and is associated with higher functional dependence and decreased quality of life. It is paramount to examine factors that potentially preserve physical performance in IWD, particularly in light of conflicting findings on the effectiveness of physical activity interventions on physical performance of IWD, mainly due to limited number of high-quality studies, large heterogeneity in methods used, or insufficient reporting of methods. The aim of this study was to investigate the effects of a 16-week multimodal exercise program (MEP) combining physical and cognitive tasks on physical performance in IWD, and to identify individual characteristics of MEP responders. Methods: A multicenter randomized controlled trial with assessment methods identified by an expert panel was conducted. We included 319 IWD of mild to moderate severity, older than 65 years, who underwent a standardized MEP specifically designed for IWD. At baseline and immediately after the MEP, we assessed physical performance (ie, mobility, balance, and strength) and function of lower extremities (primary outcomes). Potential effects of the MEP on physical performance were identified using 2-factor analyses of variance with repeated measurements within 2 samples (ie, intention-to-treat and per-protocol sample). Additionally, we compared characteristics related to physical performance between positive, non-, and negative responders. Results and Discussion: Neither analysis procedure revealed statistically significant time×group effects. However, 28% to 40% of participants were positive responders with regard to balance, and strength and function of lower extremities; and these persons had statistically significant lower baseline performance in the corresponding assessments. Conclusions: This randomized controlled trial revealed no overall effects of the MEP on physical performance, probably due to high heterogeneity of the study sample. Findings in responder analysis showed that IWD with lower physical performance at baseline tended to benefit more than those with higher baseline performance. Thus, a higher degree of individualization of the MEP depending on baseline performance on IWD may improve overall MEP effectiveness.
Automated identification of glomeruli and synchronised review of special stains in renal biopsies by machine learning and slide registration: a cross‐institutional study
Wilbur, David C. , Cornell, Lynn D. , Andryushkin, Alexander, Pettus, Jason R. , Cornell, Lynn , Smith, Maxwell L.

Mayo Clinic

Histopathology | April 4, 2021 | Volume: 79 | Issue: 4 | Pages: 499-508

10.1111/his.14376 | PMID 33813779 Get It

AimsMachine learning in digital pathology can improve efficiency and accuracy via prescreening with automated feature identification. Studies using uniform histological material have shown promise. Generalised application requires validation on slides from multiple institutions. We used machine learning to identify glomeruli on renal biopsies and compared performance between single and multiple institutions.Methods and resultsRandomly selected, adequately sampled renal core biopsy cases (71) consisting of four stains each (haematoxylin and eosin, trichrome, silver, periodic acid Schiff) from three institutions were digitised at ×40. Glomeruli were manually annotated by three renal pathologists using a digital tool. Cases were divided into training/validation (n = 52) and evaluation (n = 19) cohorts. An algorithm was trained to develop three convolutional neural network (CNN) models which tested case cohorts intra‐ and inter‐institutionally. Raw CNN search data from each of the four slides per case were merged into composite regions of interest containing putative glomeruli. The sensitivity and modified specificity of glomerulus detection (versus annotated truth) were calculated for each model/cohort. Intra‐institutional (3) sensitivity ranged from 90 to 93%, with modified specificity from 86 to 98%. Interinstitutional (1) sensitivity was 77%, with modified specificity 97%. Combined intra‐ and inter‐institutional (1) sensitivity was 86%, with modified specificity 92%.ConclusionsFeature detection sensitivity degrades when training and test material originate from different sites. Training using a combined set of digital slides from three institutions improves performance. Differing histology methods probably account for algorithm performance contrasts. Our data highlight the need for diverse training sets for the development of generalisable machine learning histology algorithms.
Improving the quality of care for patients requiring continuous renal replacement therapy
Neyra, Javier A. , Kashani, Kianoush , Kashani, Kianoush B

Mayo Clinic

Seminars in Dialysis | April 3, 2021 | Volume: 34 | Issue: 6 | Pages: 501-509

10.1111/sdi.12968 | PMID 33811790 Get It

AbstractContinuous renal replacement therapy (CRRT) is the preferred extracorporeal kidney support therapy employed to support critically ill patients with acute or chronic kidney dysfunction in intensive care units. Significant heterogeneity in CRRT practice exists in part due to variable logistics, resources, and scarcity of evidence‐based CRRT practices. Importantly, homogenization of practice patterns by developing substantial evidence and effective dissemination among providers is essential for optimizing CRRT practices. The emphasis on quality of CRRT delivery has prompted identification of potential quality indicators, development of multifaceted quality improvement initiatives, effective computer science utilization, and a surge of multidisciplinary quality assurance teams that advocate for “best” CRRT practices. This manuscript provides an overview of quality improvement methodologies and reviews candidate quality indicators of CRRT and the impact of quality improvement on enhancing CRRT delivery practices.
Reasons for discontinuation of acute postoperative pain ketamine infusions: A retrospective case‐control study
Gil, Laura Velez , Mazzeffi, Michael , Cai, Yi , McLeod, Whitney W., Gil, Laura V , Mazzeffi, Michael A , Porter, Steven B , Porter, Steven B.

Mayo Clinic

Pain Practice | April 3, 2021 | Volume: 21 | Issue: 7 | Pages: 759-765

10.1111/papr.13012 | PMID 33811788 Get It

AbstractPurposeThe purpose of the study was to investigate factors associated with early discontinuation of low‐dose ketamine infusions due to adverse drug events (ADEs).MethodsA retrospective, matched case‐control study of surgical patients who received low‐dose ketamine infusions for postoperative pain over 6 years was conducted. Forty‐seven study patients, who required early discontinuation of their infusion due to ADEs, were included and matched 1:1 with 47 controls, who did not experience ADEs, for a total of 94 patients. The two groups were compared based on surgery type, American Society of Anesthesiologists (ASA) classification, administration of specific perioperative anxiolytic, anesthetic, and analgesic medications, and use of regional anesthesia.ResultsOf the study patients, 44.7% underwent spine procedures (vs. 34% of controls), 27.6% underwent abdominal procedures (vs. 8.5% of controls), 19.2% underwent orthopedic procedures (vs. 46.8% of controls), and 8.5% underwent thoracic procedures (vs. 6.4% of controls). There were no statistically significant differences in ASA classification, pre‐operative gabapentinoid and antidepressant use, average ketamine infusion dose, or postoperative use of peripheral nerve catheters, nonsteroidal anti‐inflammatory drugs (NSAIDs), acetaminophen, muscle relaxants, and nonbenzodiazepine sleep aides. Study patients had higher rates of intra‐operative volatile anesthetic use (78.7% vs. 57.7%, p = 0.03) and more postoperative opioid patient‐controlled analgesia (PCA) use (53.2% vs. 29.8%, p = 0.02) than controls. Control patients had higher rates of preoperative opioid use (76.7% vs. 53.2%, p = 0.02) and premedication with midazolam (89.4% vs. 70.2%, p = 0.02) than study patients.ConclusionPatients who required discontinuation of their low‐dose ketamine infusion due to ADEs were more likely to be opioid naïve, received less pre‐operative benzodiazepines, and had greater postoperative opioid PCA requirements. Control patients, on the other hand, had higher rates of pre‐operative opioid use and experienced fewer ADEs despite greater total ketamine doses.
Temporary, Percutaneous Peripheral Nerve Stimulation for Refractory Occipital Neuralgia
Moman, Rajat N. , Olatoye, Oludare, Pingree, Matthew J. , Moman, Rajat

Mayo Clinic

Pain Medicine | April 3, 2021 | Volume: 23 | Issue: 2 | Pages: 415-420

10.1093/pm/pnab128 | PMID 33823015 Get It

Giant Cell Arteritis: A Systematic Review and Meta‐Analysis of Test Accuracy and Benefits and Harms of Common Treatments
Dua, Anisha B. , Husainat, Nedaa , Kalot, Mohamad A. , Byram, Kevin , Springer, Jason , James, Karen , Lin, Yih Chang, Turgunbaev, Marat, Villa‐Forte, Alexandra, Abril, Andy , Langford, Carol A. , Maz, Mehrdad , Husainat, Nedaa M , Springer, Jason M , Mustafa, Reem A , Kalot, Mohamad A , Dua, Anisha B , Chung, Sharon A.

Mayo Clinic

ACR Open Rheumatology | April 3, 2021 | Volume: 3 | Issue: 7 | Pages: 429-441

10.1002/acr2.11226 | PMID 33811481 Get It

This systematic review compares treatment options for patients with giant cell arteritis (GCA) and evaluates the test accuracy of studies used in diagnosing and monitoring GCA. These studies were used to inform evidence‐based recommendations for the American College of Rheumatology (ACR)/Vasculitis Foundation (VF) vasculitis management guidelines. A systematic review and search of articles in English in Ovid Medline, PubMed, Embase, and the Cochrane Library was conducted. Articles were screened for suitability, and studies presenting the highest level of evidence were given preference. Three hundred ninety‐nine full‐text articles addressing GCA questions were reviewed to inform 27 Population, Intervention, Comparison, and Outcome questions. No benefit was found with intravenous glucocorticoids (GCs) compared with high‐dose oral GCs in patients with cranial ischemic symptoms (27.4% vs 12.3%; odds ratio [OR] 2.39 [95% confidence interval (CI) 0.75‐7.62], [very low certainty of evidence]). Weekly tocilizumab with a 26‐week GC taper was superior to a 52‐week GC taper in patients achieving remission (risk ratio 4.00 [95% CI 1.97‐8.12], [low certainty of evidence]). Non‐GC immunosuppressive therapies with GCs compared with GCs alone showed no statistically significant in relapse at 1 year (OR 0.87 [95% CI 0.73‐1.04], [moderate certainty of evidence]) or serious adverse events (OR 0.81 [95% CI 0.54‐1.20]; [moderate certainty of evidence]). Temporal artery biopsy has a sensitivity of 61% (95% CI 38%‐79%) and a specificity of 98% (95% CI 95%‐99%) in patients with a clinical diagnosis of suspected GCA. This comprehensive systematic review synthesizes and evaluates the benefits and harms of different treatment options and the accuracy of commonly used tests for the diagnosis and monitoring of GCA.
Clinical Whole-Exome Sequencing Analysis Reveals a Novel Missense COL11A1 Mutation Resulting in an 18-Week Iranian Male Aborted Fetus with Fibrochondrogenesis 1: A Case Report
Ajami, Sanaz, Mehrtash, Amirhosein, Marashiyan, Seyedeh Mahya, Bahreini, Farbod , Ghanbari, Sogol , Ardeshirdavani, Amin , Mirtavoos‐Mahyari, Hanifeh , Ajami, Sanaz, Sheikhy, Kambiz

Mayo Clinic

No container title available | April 2, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-369154/v1 Get It

Abstract BackgroundFibrochondrogenesis 1, an autosomal recessive syndrome, is an infrequent and rare disease, causing short-limbed skeletal dysplasia. This syndrome is clinically characterized and distinguished by a small nose and anteverted bares, flat midface, shortened long bones, and a protuberant abdomen. Mutations in the gene encoding the α1 chain of type XI collagen (COL11A1) are seen to be the main cause of this disease.Case PresentationWe present an 18-week Iranian male aborted fetus with Fibrochondrogenesis 1 from consanguineous parents. Whole-exome sequencing (WES) revealed a novel missense variant from G to A in exon 45 of 68 in the COL11A1 gene (NM_080629.2: c.3440G>A, [p.G1147E, g.103404625]). The mutation was confirmed by Sanger sequencing and further, MutationTaster predicted this variant to be disease-causing.ConclusionBioinformatic analysis suggests that this variant is highly conserved in both nucleotide and protein levels, suggesting that it has an important function in the proper role of COL11A1 protein. In-silico analysis suggests that this mutation alters the COL11A1 protein structure through a Glycine to Glutamic acid substitution. This is a novel mutation and a rare variant as this variant is not reported in gmomAD, ExAC, or 1000 genome databases.To the best of the authors’ knowledge, this is the first study to report a novel pathogenic mutation in COL11A1 in association with Fibrochondrogenesis 1. Therefore, we suggest that WES can be used as a robust method to achieve rapid diagnosis and identification of pathogenic and novel mutations in patients.
Rapidly developing, large pyogenic liver abscesses in the setting of pancreatic cancer
Pruden, Kathryn, Mohseni, Michael , Kwon, Joshua , Mohseni, Michael M., Mohseni, Michael M

Mayo Clinic

Baylor University Medical Center Proceedings | April 2, 2021 | Volume: 34 | Issue: 4 | Pages: 507-509

10.1080/08998280.2021.1901835 | PMID 34219941 Get It

Bedside Clinicians’ Perceptions on the Contributing Role of Diagnostic Errors in Acutely Ill Patient Presentation: A Survey of Academic and Community Practice
Huang, Chanyan, Barwise, Amelia, Soleimani, Jalal, Dong, Yue, Svetlana, Herasevich, Khan, Syed Anjum, Gavin, Anne, Helgeson, Scott A., Moreno-Franco, Pablo, Pinevich, Yuliya, Kashyap, Rahul, Herasevich, Vitaly, Gajic, Ognjen, Pickering, Brian W., Barwise, Amelia , Huang, Chanyan , Barwise, Amelia K , Huang, Chanyan, Soleimani, Jalal, Dong, Yue, Svetlana, Herasevich, Khan, Syed Anjum, Gavin, Anne, Helgeson, Scott A., Moreno-Franco, Pablo, Pinevich, Yuliya, Kashyap, Rahul, Herasevich, Vitaly, Gajic, Ognjen, Pickering, Brian W.

Mayo Clinic

Journal of Patient Safety | April 2, 2021 | Volume: 18 | Issue: 2 | Pages: e454-e462

10.1097/pts.0000000000000840 | PMID 35188935 Get It

Objectives This study aimed to explore clinicians’ perceptions of the occurrence of and factors associated with diagnostic errors in patients evaluated during a rapid response team (RRT) activation or unplanned admission to the intensive care unit (ICU). Methods A multicenter prospective survey study was conducted among multiprofessional clinicians involved in the care of patients with RRT activations and/or unplanned ICU admissions (UIAs) at 2 academic hospitals and 1 community-based hospital between April 2019 and March 2020. A study investigator screened eligible patients every day. Within 24 hours of the event, a research coordinator administered the survey to clinicians, who were asked the following: whether diagnostic errors contributed to the reason for RRT/UIA, whether any new diagnosis was made after RRT/UIA, if there were any failures to communicate the diagnosis, and if involvement of specialists earlier would have benefited that patient. Patient clinical data were extracted from the electronic health record. Results A total of 1815 patients experienced RRT activations, and 1024 patients experienced UIA. Clinicians reported that 18.2% (95/522) of patients experienced diagnostic errors, 8.0% (42/522) experienced a failure of communication, and 16.7% (87/522) may have benefitted from earlier involvement of specialists. Compared with academic settings, clinicians in the community hospital were less likely to report diagnostic errors (7.0% versus 22.8%, P = 0.002). Conclusions Clinicians report a high rate of diagnostic errors in patients they evaluate during RRT or UIAs.
Clinical predictors of non‐response to lithium treatment in the Pharmacogenomics of Bipolar Disorder (PGBD) study
Lin, Yian , Maihofer, Adam X. , Stapp, Emma K. , Ritchey, Megan, Anand, Amit , Balaraman, Yokesh, Berrettini, Wade H. , Bertram, Holli , Bhattacharjee, Abesh Kumar, Calkin, Cynthia , Conroy, Carla , Coryell, William , D’Arcangelo, Nicole, DeModena, Anna, Fisher, Carrie, Frazier, Nicole, Frye, Mark A. , Gao, Keming , Glazer, Kara, Karberg, Elizabeth , Harrington, Gloria, Kamali, Masoud , Kelly, Marisa , Leckband, Susan G. , Lohoff, Falk W. , Stautland, Andrea , McCarthy, Michael J. , McInnis, Melvin G. , Mondimore, Francis M. , Øedegaard, Ketil J. , Syrstad, Vigdis Elin Giever, Ryan, Kelly A. , Schinagle, Martha , Schoeyen, Helle K., Shaw, Marth, Shilling, Paul D. , Slaney, Claire , Tarwater, Bruce, Calabrese, Joseph R. , Zandi, Peter P. , Anand, Amit , Coryell, William , Biernacka, Joanna , Frye, Mark, Gao, Keming , Nurnberger, John I , Alda, Martin , Zandi, Peter P , Kamali, Masoud , Calkin, Cynthia V , McCarthy, Michael , McInnis, Melvin G , Ritchey, Megan, Alliey‐Rodriguez, Ney , Biernacka, Joanna M. , Garnham, Julie , Gershon, Elliot S. , Goes, Fernando , Goto, Toyomi , Karberg, Elizabeth, Jakobsen, Petter , Morken, Gunnar , Syrstad, Vigdis Elin Giæver , Andreassen, Ole A. , Alda, Martin , Nievergelt, Caroline M , Kelsoe, John R

Mayo Clinic

Bipolar Disorders | April 2, 2021 | Volume: 23 | Issue: 8 | Pages: 821-831

10.1111/bdi.13078 | PMID 33797828 Get It

AbstractBackgroundLithium is regarded as a first‐line treatment for bipolar disorder (BD), but partial response and non‐response commonly occurs. There exists a need to identify lithium non‐responders prior to initiating treatment. The Pharmacogenomics of Bipolar Disorder (PGBD) Study was designed to identify predictors of lithium response.MethodsThe PGBD Study was an eleven site prospective trial of lithium treatment in bipolar I disorder. Subjects were stabilized on lithium monotherapy over 4 months and gradually discontinued from all other psychotropic medications. After ensuring a sustained clinical remission (defined by a score of ≤3 on the CGI for 4 weeks) had been achieved, subjects were followed for up to 2 years to monitor clinical response. Cox proportional hazard models were used to examine the relationship between clinical measures and time until failure to remit or relapse.ResultsA total of 345 individuals were enrolled into the study and included in the analysis. Of these, 101 subjects failed to remit or relapsed, 88 achieved remission and continued to study completion, and 156 were terminated from the study for other reasons. Significant clinical predictors of treatment failure (p < 0.05) included baseline anxiety symptoms, functional impairments, negative life events and lifetime clinical features such as a history of migraine, suicidal ideation/attempts, and mixed episodes, as well as a chronic course of illness.ConclusionsIn this PGBD Study of lithium response, several clinical features were found to be associated with failure to respond to lithium. Future validation is needed to confirm these clinical predictors of treatment failure and their use clinically to distinguish who will do well on lithium before starting pharmacotherapy.